Amazon: Consensus Price Target Falls After Disappointing Q2 Results

Amazon.com Inc (NASDAQ: AMZN) reported its second quarter financial results on July 29. The company did not continue the earnings beat like its counterparties reported this quarter. The company reported top-line revenue of $113.08 billion, coming in below the $115.14 billion consensus estimate. Revenue grew 27.2% year over year and gross profit grew 34.9% year over year to $48.9 billion. Gross margin came in at 43.2% and operating margin was only 6.8% for the quarter. The company’s net income was $7.77 billion and earnings per share came in at $15.13.

Analysts have had mixed feelings about the results, resulting in the consensus 12-month price target dropping to $4,171.76 from $4,264.77 from before the results were released. Susquehanna Financial has the street high at $5,000 while the lowest 12-month price target comes in at $3,775. Out of the 53 analysts covering the stock, 20 have strong buy ratings, 31 have buys and 2 analysts have hold ratings.

BMO Capital Markets lowered their 12-month price target on Amazon to $4,100 from $4,300 and reiterate their outperform rating, saying that the company had much tougher comps this quarter than other tech companies.

Amazon’s total revenue of $113.1 billion was behind BMO’s estimate of $113.6 billion, but Amazon beat every single business segment, except for online stores. Amazon’s executives explain on the call that there was slower growth in the online space due to lockdown restrictions easing and people spending money on those things rather than online. BMO says that third-quarter guidance also of $106-$112 billion came in a lot lower than their $116 billion estimate.

BMO Capital Markets says that they are left with a few final thoughts coming out of the call, including that AWS growth remains consistent at 30% and that Amazon, “remains at the center of the two most important growth segments in digital advertising: retail media (e.g. Sponsored Product ads) and connected TV.”

Below you can see BMO’s updated third quarter, 2021, and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Amid CBS Shuffle, Is Joe Rogan Replacing Anderson Cooper On 60 Minutes?

Silver47 Targets Resource Growth With 10,000 Metre Red Mountain Drill Program

Related News

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM

Cineplex: BMO Reiterates Targets Despite Earnings Missing Consensus

Cineplex Inc. (TSX: CGX) reported its second quarter financial results last week. The company announced...

Monday, August 15, 2022, 12:24:00 PM

Canaccord Lowers Else Nutrition Estimates After Disappointing Quarter

This past week, Else Nutrition (CSE: BABY) reported their second quarter financial results. The company...

Friday, September 3, 2021, 11:11:00 AM

AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August...

Wednesday, August 3, 2022, 02:21:00 PM

Well Health: Consensus Price Target Climbs To $11.83 Following MyHealth Acquisition

WELL Health Technologies Corp. (TSX: WELL) this week announced that they would be acquiring MyHealth...

Thursday, June 10, 2021, 11:46:00 AM